As the Table 3 showed, the univariate analysis identified the CRP (p = 0.012), Lymph node metastasis (p = 0.021), time to recurrence (p = 0.001), and the follow-up treatment (p = 0.011) were prognostic factors. This evidence concerns the gene CRP and metastatic malignant neoplasm in the lymph nodes.